Skip to content
Company Analysis

iRhythm Technologies, Inc. IRTC

A comprehensive view of key metrics, scores, and financial health for iRhythm Technologies, Inc.

Overview of iRhythm Technologies, Inc.

IRTC NMS
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Mid Cap
iRhythm Technologies, Inc. (IRTC), is a Mid Cap company, in the Medical Devices industry, last closed at $126.17, about 75.4% overvalued vs fair value, -28.9% 1Y return, placing in the top 25% of its sector.
Metrics Rev Growth 26.2% ROE -36.6% Gross Margin 70.6%
USD 126.17
2.27%
(Delayed)
• Vol 90d: 42.9%
52-Week Range
Market Cap
$4.16B
Enterprise Value
$4.56B
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Good
Health
Good
Efficiency
Good
Valuation
Good
Growth
Good
Profitability
Good
Health
Good
Efficiency
Good
Valuation
Good
Completeness: 88%
Confidence: 93%
Updated: Oct 31
Top Beats

Quick Facts

Website https://www.irhythmtech.com
HQ San Francisco, CA
Employees 2,400
Fiscal year Dec 31

Next Events

Earnings Nov 5 Call: Nov 5

Fair Value Snapshot

Bear Base Bull
$27
$31
$36
Current: $126.17 -75% vs base

Engine Room Money Flow™

Mid Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$747.1M
26.2%%
Gross Profit
$527.2M
29.4%%
Operating Income (GAAP)
-$57.4M
50.3%%
EBITDA
-$4.0M
94.7%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
70.6%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
6
Active Leaks
5/6
Improving
0
High Impact
4
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating iRhythm Technologies, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
65
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Strong FCF Generation FCF margin quality is top-tier vs peers (score 0.77). High FCF conversion confirms strong earnings quality.
  • Strong Operating Margin vs Peers Operating margin level is strong vs peers (score 0.69). SG&A discipline is converting gross margin into operating profit efficiently.

Key risks

  • Elevated Leverage Leverage is elevated vs peers (score 0.07). High net debt/EBITDA limits the balance sheet's acquisition firepower.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
75
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 83% Coverage
Trade-Off Triangle Visualization A ternary plot showing IRTC's balance between Growth (41.9%), Profitability (35.2%), and Safety (22.9%). Growth 42% Safety 23% Profitability 35%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

77th percentile vs peers
77
Key Signals
Rev Growth YoY 26.2% 83p Revenue CAGR 3Y 22.1% 75p EPS Growth YoY 61.7% 72p Asset Growth YoY 9.5% 68p
Strengths
  • Rev Growth YoY in top 20% of peers (26.2%, 83th percentile)
  • Cash Flow to Debt Ratio in top 20% of peers (2.74, 90th percentile)
  • Growth above peer median with strong metric coverage (75%)
  • Consistently strong margins across 3 metrics
Risks

No significant risks identified for this axis.

Profitability

64th percentile vs peers
65
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

42th percentile vs peers
42
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for iRhythm Technologies, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$30.99
- - -
-75.4% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000